睾酮替代治疗是否增加全髋或全膝关节置换术后血栓形成风险
该回顾性匹配队列研究利用2005至2025年全国登记数据,纳入640,219例初次全髋(265,477例)或全膝(374,742例)关节置换患者,按术前或术后三个月内是否接受睾酮替代治疗分层。结果显示,全膝置换患者中接受睾酮替代治疗者肺栓塞发生率显著升高(OR=1.45;95%CI 1.04至2.02;P=0.029),深静脉血栓无显著差异;全髋置换患者中肺栓塞和深静脉血栓均无显著差异。
要点
- 全膝置换患者接受睾酮替代治疗与肺栓塞风险升高相关(OR=1.45;95%CI 1.04至2.02;P=0.029)。
- 全膝置换患者接受睾酮替代治疗与深静脉血栓无显著差异(OR=1.27;95%CI 0.98至1.65;P=0.073)。
- 全髋置换患者接受睾酮替代治疗与肺栓塞(OR=1.35;95%CI 0.88至2.05;P=0.166)及深静脉血栓(OR=1.26;95%CI 0.89至1.77;P=0.192)均无显著差异。
核心结论
- 睾酮替代治疗与全膝置换术后肺栓塞发生率显著升高相关,但与深静脉血栓无显著相关;全髋置换术后睾酮替代治疗与静脉血栓栓塞无显著差异。
- 随着关节置换患者与接受睾酮替代治疗患者的重叠增加,骨科医生应了解睾酮替代治疗相关的风险。
研究设计与样本
- 回顾性匹配队列研究,使用全国登记数据识别2005年至2025年期间接受初次全髋或全膝置换的患者。
- 共纳入640,219例患者,其中全髋置换265,477例,全膝置换374,742例;按关节置换术前或术后三个月内是否处方睾酮进行分层。
- 全髋置换中1,469例(0.6%)、全膝置换中2,032例(0.5%)在术前或术后三个月内被处方睾酮;平衡人口学和合并症后创建匹配队列。
- 主要结局为关节置换术后三个月内的深静脉血栓或肺栓塞;使用关联模型计算比值比(OR)。
主要发现
- 全膝置换患者中,接受睾酮替代治疗者肺栓塞发生率较未接受者显著升高(OR=1.45;95%CI 1.04至2.02;P=0.029)。
- 全膝置换患者中,接受睾酮替代治疗者深静脉血栓发生率与未接受者无显著差异(OR=1.27;95%CI 0.98至1.65;P=0.073)。
- 全髋置换患者中,接受与未接受睾酮替代治疗者肺栓塞发生率无显著差异(OR=1.35;95%CI 0.88至2.05;P=0.166)。
- 全髋置换患者中,接受与未接受睾酮替代治疗者深静脉血栓发生率无显著差异(OR=1.26;95%CI 0.89至1.77;P=0.192)。
临床怎么用
- 原文结论指出,随着关节置换患者与接受睾酮替代治疗患者的重叠增加,骨科医生应了解睾酮替代治疗相关的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Testosterone is a prothrombotic hormone, but the effect of exogenous testosterone on venous thromboembolic events (VTEs) following total joint arthroplasty (TJA) remains unclear. This study investigated the association between testosterone replacement therapy (TRT) and postoperative risk of VTE following primary total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: We conducted a retrospective, matched cohort study using a national registry to identify primary THA or primary TKA patients from the years 2005 to 2025. Patients were stratified by TRT within three months of the TJA. There were 640,219 patients who had a THA (265,477) or a TKA (374,742) that were included. There were 1,469 THA (0.6%) and 2,032 (0.5%) TKA patients who were prescribed testosterone within three months before or after their TJA. A matched cohort was created after balancing demographics and comorbidities. Primary outcomes were DVT or pulmonary embolism (PE) within three months after their TJA. Measures of association models were used to calculate odds ratios (ORs). RESULTS: We found a statistically significant increase in the rate of PE in TKA patients on TRT compared to those who were not (OR = 1.45; 95% confidence interval (CI), 1.04 to 2.02; P = 0.029). Rates of DVT in TKA patients on TRT were similar to those not on TRT (OR = 1.27; 95% CI, 0.98 to 1.65; P = 0.073). Similarly, there were no statistically significant differences in rates of PE (OR = 1.35; 95% CI, 0.88 to 2.05; P = 0.166) or DVT (OR = 1.26; 95% CI, 0.89 to 1.77; P = 0.192) between THA patients regarding TRT. CONCLUSIONS: TRT was associated with a statistically significant increased rate of PE following TKA but not for DVT. Similarly, no significant difference was observed between TRT and VTE following THA. As the overlap between arthroplasty patients and patients on TRT increases, orthopaedic surgeons should be aware of the risks associated with TRT.
引用
- Ni A, Cal E, Martinez V, et al. Does Testosterone Replacement Therapy Increase Risk of Thrombosis After Total Hip or Knee Arthroplasty? J Arthroplasty. 2025. PMID: 41276233. doi:10.1016/j.arth.2025.11.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。